ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

被引：0
|
作者：
Jordan M Reese
Vera J Suman
Malayannan Subramaniam
Xianglin Wu
Vivian Negron
Anne Gingery
Kevin S Pitel
Sejal S Shah
Heather E Cunliffe
Ann E McCullough
Barbara A Pockaj
Fergus J Couch
Janet E Olson
Carol Reynolds
Wilma L Lingle
Thomas C Spelsberg
Matthew P Goetz
James N Ingle
John R Hawse
机构：
[1] Mayo Clinic,Department of Biochemistry and Molecular Biology
[2] Mayo Clinic,Department of Molecular Pharmacology and Experimental Therapeutics
[3] Mayo Clinic,Department of Biomedical Statistics and Informatics
[4] Mayo Clinic,Department of Laboratory Medicine and Pathology
[5] University of Otago,The Department of Pathology, Dunedin School of Medicine
[6] Mayo Clinic,Department of Laboratory Medicine and Pathology
[7] Mayo Clinic,Department of Surgery
[8] Mayo Clinic,Department of Health Sciences Research
[9] Mayo Clinic,Department of Oncology
来源：
BMC Cancer | / 14卷
关键词：
Estrogen receptor beta; Breast cancer; Estrogen receptor alpha; Triple negative breast cancer; Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
    Reese, Jordan M.
    Suman, Vera J.
    Subramaniam, Malayannan
    Wu, Xianglin
    Negron, Vivian
    Gingery, Anne
    Pitel, Kevin S.
    Shah, Sejal S.
    Cunliffe, Heather E.
    McCullough, Ann E.
    Pockaj, Barbara A.
    Couch, Fergus J.
    Olson, Janet E.
    Reynolds, Carol
    Lingle, Wilma L.
    Spelsberg, Thomas C.
    Goetz, Matthew P.
    Ingle, James N.
    Hawse, John R.
    [J]. BMC CANCER, 2014, 14
  • [2] Bioinformatics Identification of TUBB as Potential Prognostic Biomarker for Worse Prognosis in ERα-Positive and Better Prognosis in ERα-Negative Breast Cancer
    Alhammad, Rashed
    [J]. DIAGNOSTICS, 2022, 12 (09)
  • [3] Overview of the therapeutic strategies for ER positive breast cancer
    Blakely, Brianna
    Shin, Seobum
    Jin, Kideok
    [J]. BIOCHEMICAL PHARMACOLOGY, 2023, 212
  • [4] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    Jordan, VC
    [J]. BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S4 - S4
  • [5] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    VC Jordan
    [J]. Breast Cancer Research, 7
  • [6] Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer
    Peng Su
    Jing Hu
    Hui Zhang
    Ming Jia
    Weiwei Li
    Xuanxuan Jing
    Gengyin Zhou
    [J]. Diagnostic Pathology, 9
  • [7] An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment
    Tang, Jianing
    Cui, Qiuxia
    Zhang, Dan
    Liao, Xing
    Zhu, Jian
    Wu, Gaosong
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (08) : 4980 - 4990
  • [8] Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer
    Su, Peng
    Hu, Jing
    Zhang, Hui
    Jia, Ming
    Li, Weiwei
    Jing, Xuanxuan
    Zhou, Gengyin
    [J]. DIAGNOSTIC PATHOLOGY, 2014, 9
  • [9] An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
    Zhou, Xin
    Wang, Xiaping
    Huang, Zebo
    Xu, Lei
    Zhu, Wei
    Liu, Ping
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2014, 33
  • [10] An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
    Xin Zhou
    Xiaping Wang
    Zebo Huang
    Lei Xu
    Wei Zhu
    Ping Liu
    [J]. Journal of Experimental & Clinical Cancer Research, 33
12345